Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology - Clinical Diagnosis: Solid Tumors

Role of dual time point FDG PET imaging in differentiating axillary lesion in breast cancer

Ayse Mavi, Tevfik Cermik, Sandip Basu, Muammer Urhan, Brian Czerniecki and Abass Alavi
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1735;
Ayse Mavi
1Yeditepe University Hospital, Dept. Nuclear Medicine, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tevfik Cermik
2University of Pennsylvania, Div. Nuclear Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandip Basu
2University of Pennsylvania, Div. Nuclear Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muammer Urhan
2University of Pennsylvania, Div. Nuclear Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Czerniecki
2University of Pennsylvania, Div. Nuclear Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abass Alavi
2University of Pennsylvania, Div. Nuclear Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1735

Objectives This prospective study was aimed to determine if dual time point imaging can improve the sensitivity and the specificity of PET for detection of axillary metastatic lesions.

Methods Newly diagnosed 180 breast cancer patients underwent dual time point PET (SUVmax) was measured from axillary lesion from both time points. The percent change in SUVmax (▵%SUVmax) between first and second scans(SUVmax1 and SUVmax2) was calculated. Sentinel node biopsy was performed. True and false positive rates were calculated according to pathology and SUV calculations were compared .

Results Dual time PET findings were positive for axillary metastasis in 45 patients, 27 of them had axillary metastasis confirmed by histopathology while 18 were found to be false positive likely due to diagnostic biopsy. The SUVmax1, SUVmax2 and ▵%SUVmax were 3.5±2.2, 4.0±2.5 and 8.9±12.5% in true positive group while those were 2.1±2.2, 2.1±2.0 and ─0.4±25.1% in false positive group, respectively. The comparisons were significant (p=0.006, p=0.001 and 0.043, respectively) .

Conclusions The true positive axillary metastatic lesions had higher SUVmax values and showed an increase over time while false positive lesions had lower SUVmax and was either stable or showed a decrease over time. Dual time point imaging may allow differentiating true positive axillary metastasis from false positive nodes.

  • © 2009 by Society of Nuclear Medicine
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of dual time point FDG PET imaging in differentiating axillary lesion in breast cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Role of dual time point FDG PET imaging in differentiating axillary lesion in breast cancer
Ayse Mavi, Tevfik Cermik, Sandip Basu, Muammer Urhan, Brian Czerniecki, Abass Alavi
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1735;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of dual time point FDG PET imaging in differentiating axillary lesion in breast cancer
Ayse Mavi, Tevfik Cermik, Sandip Basu, Muammer Urhan, Brian Czerniecki, Abass Alavi
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1735;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology - Clinical Diagnosis: Solid Tumors

  • Prediction of therapy outcome in patients with high risk soft tissue sarcoma using dynamic FDG studies
  • Ovarian F-18 FDG uptake in postmenopausal thyroidectomised patients in TSH-stimulated FDG PET/CT
  • Ga-68 DOTATE PET in endocrine tumors: Comparison with SRS, dosimetry, clinical impact
Show more Oncology - Clinical Diagnosis: Solid Tumors

Breast/Gynecology/Neuroendocrine/Melanoma/Other Posters

  • Preliminary experience on the use of 68Ga-DOTA-NOC PET to study patients with paraganglioma
  • Assessment of somatostatin receptor expression in the management of
  • The role of 99mTc-tetrofosmin molecular breast imaging (MBI) in patients with breast lesions
Show more Breast/Gynecology/Neuroendocrine/Melanoma/Other Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire